Zobrazeno 1 - 10
of 248
pro vyhledávání: '"Hideo AKIYAMA"'
Autor:
Keisuke Nitta, Tomoko Miyakubo, Shunsuke Tokui, Mayuko Takayama, Yoichiro Shinohara, Kazuma Saito, Tomomi Endo, Hideo Akiyama
Publikováno v:
Indian Journal of Ophthalmology, Vol 72, Iss 11, Pp 1659-1662 (2024)
In this study, we validated the new technique for inserting the tube of the Ahmed glaucoma valve (AGV) into the ciliary sulcus. AGV tube insertion was performed by introducing a 4-0 nylon thread into the anterior chamber from the corneal incision on
Externí odkaz:
https://doaj.org/article/b398b968d8d14b4786c675b3526196b2
Autor:
Hidetaka Matsumoto, MD, PhD, Shoji Kishi, MD, PhD, Junki Hoshino, MD, Kosuke Nakamura, MD, Hideo Akiyama, MD, PhD
Publikováno v:
Ophthalmology Science, Vol 4, Iss 5, Pp 100515- (2024)
Purpose: Intervortex venous anastomosis is widely recognized as compensating for vortex vein congestion in pachychoroid spectrum diseases. However, determining the blood flow direction within the compensated drainage route is often challenging. Herei
Externí odkaz:
https://doaj.org/article/d1c5b56c011b4ee382f96085738ac0c9
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract We investigated the assessment of blood flow within polypoidal lesions using optical coherence tomography angiography (OCTA) to determine intravitreal brolucizumab (IVBr) efficacy for treating polypoidal choroidal vasculopathy (PCV). We retr
Externí odkaz:
https://doaj.org/article/d52c4348f53345b1932a803ba528535f
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract We retrospectively studied 12 eyes of 12 patients with central serous chorioretinopathy (CSC) to investigate choroidal thickness changes following half-fluence photodynamic therapy (PDT) using widefield choroidal thickness maps obtained by o
Externí odkaz:
https://doaj.org/article/57ebe6e8cc95441bb0e0621ba70ee075
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Anti-Cytotoxic T-Lymphocyte Associated protein 4 agents, such as ipilimumab, are widely applied to various cancers. However, they cause immune-related adverse effects throughout the body, including the eye. This study examined whether ipilim
Externí odkaz:
https://doaj.org/article/f7508620b8f049b9905e10ddd6a1cfd4
Autor:
Daisuke Todokoro, Tomoko Miyakubo, Aya Komori, Takashi Tamura, Koichi Makimura, Hideo Akiyama
Publikováno v:
Case Reports in Ophthalmology, Vol 14, Iss 1, Pp 153-158 (2023)
Mooren’s ulcer is an idiopathic peripheral ulcerative keratitis whose pathogenesis is thought to be due to an autoimmune reaction. The first-line treatment for Mooren’s ulcer is the use of topical steroids, which can be difficult to discontinue.
Externí odkaz:
https://doaj.org/article/c44cc2cc8eb046a884a485c8ed648936
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract We previously reported one-year results of a treat-and-extend (TAE) regimen with intravitreal brolucizumab for 68 eyes with treatment-naïve neovascular age-related macular degeneration (nAMD) associated with type 1 macular neovascularizatio
Externí odkaz:
https://doaj.org/article/c7e86f10983e498fbdae95a3096d0b4a
Publikováno v:
BMC Ophthalmology, Vol 22, Iss 1, Pp 1-6 (2022)
Abstract Background To compare the regressive effects of aflibercept and brolucizumab on pigment epithelial detachment (PED) in age-related macular degeneration. Methods Eighty-three eyes of 83 patients diagnosed with type 1 macular neovascularizatio
Externí odkaz:
https://doaj.org/article/aee9f5d4a10a4517ba23444134e4907f
Autor:
Yoichiro Shinohara, Daisuke Todokoro, Rei Yamaguchi, Masahiko Tosaka, Yuhei Yoshimoto, Hideo Akiyama
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract The study investigated clinical features of sellar and suprasellar tumors with optic nerve bending. Twenty-five patients (13 men/12 women; age, 59.0 ± 12.9 years) with optic nerve bending in one eye who underwent tumor resection for sellar
Externí odkaz:
https://doaj.org/article/fffa193b911e4580834a65597dff6169
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract We evaluated 1-year outcomes of loading phase treatment followed by maintenance treatment using a treat-and-extend (TAE) regimen with intravitreal brolucizumab for neovascular age-related macular degeneration (nAMD) associated with type 1 ma
Externí odkaz:
https://doaj.org/article/901c3b7a133f4dd89c46093cab07ff8b